Allspring Global Investments
ERNA icon

Allspring Global Investments’s Eterna Therapeutics ERNA Stock Holding History

Allspring Global Investments’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed -$241K – 2755
2022
Q1 		$241K Buy
16
+7
+78% +$133K ﹤0.01% 2509
2021
Q4 		$276K Buy
+9
New +$490K ﹤0.01% 2536

Other funds holding ERNA

CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Allspring Global Investments's ERNA Position: Q2 2022 in Review

Allspring Global Investments sold out of Eterna Therapeutics (ERNA) in Q2 2022, closing a stake of 16 shares — an estimated $241K sold.

Allspring Global Investments first reported a position in ERNA in Q4 2021 and held it in 2 quarters. The position peaked at $276K in Q4 2021. 34 funds tracked by Wall St. Rank hold ERNA as of Q2 2022.

  • Allspring Global Investments reported no remaining Eterna Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 16 Eterna Therapeutics shares in Q2 2022, an estimated $241K.
  • Allspring Global Investments first reported a position in Eterna Therapeutics in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Eterna Therapeutics position peaked at $276K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.